As artificial intelligence plays a greater role throughout the insurance industry, questions arise about AI risk, how it's ...

Biomarker testing helps doctors create personalized cancer treatments with fewer side effects. Many health insurers deny coverage for this testing, calling it "experimental." Lack of insurance ...

While news that the inflation rate remains stubbornly above goal was greeted enthusiastically by millions of Americans when released earlier this month, it was arguably worse news for seniors and ...

Medicaid and the Children’s Health Insurance Program (CHIP) play critical roles in US child health coverage, but children frequently endure uninsured periods, and recent federal health policy changes ...

Equity gaps in lung cancer molecular testing persist; reflex testing and nurse navigation speed care, while coverage and access barriers stall outcomes Delays in care remain a critical issue. D’Avella ...

Ben Urick, PharmD, PhD, examines GLP-1 coverage gaps and real-world evidence challenges shaping payer decisions and obesity treatment access. Glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...